Individuals can anticipate improved blood sugar control, noticeable weight loss, potential positive effects on heart health, and a simpler dosing regimen, offering convenience in managing weight loss.

Significant reduction in hemoglobin A1C levels

Weight loss up to 10-15% of body weight

Lowering of blood pressure by average of 2-6 mmHg

Reduction in risk of kidney damage

Decrease in risk of cardiovascular events by approximately 20-30%

Higher metabolism

Improvement of cholesterol levels

Semaglutide is a medication that is commonly used in the treatment of type 2 diabetes. The compound is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it minimizes GLP-1 hormone and makes you feel less hungry. When you eat, your digestive tract releases the GLP-1 hormone, prompting the body to create more insulin. It also sends fullness signals to the brain.

175 patients determined to be overweight or obese lost an average of 5.9% of their body weight at 3 months, and 10.9% at six months.

Treatment recommended for anyone with a BMI greater than 26 and/or one or more weight-related medical problems.

One weekly subcutaneous injections for 3 to 6 months. Dosage is increased as needed until maintenance weight is achieved.